Cancer in 15- to 29-Year-Olds by Primary Site-Reference-Cited by-同舟云学术

Cancer in 15- to 29-Year-Olds by Primary Site

Published:2006-06-01 Issue:6 Volume:11 Page:590-601
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Bleyer Archie¹,Viny Aaron²,Barr Ronald³

Affiliation:

1. a Cancer Treatment Center, St. Charles Medical Center, Bend, Oregon, USA

2. b Clevelend Clinic Lerner College of Medicine, Cleveland, Ohio, USA

3. c Department of Pediatrics, Pathology, and Medicine, McMaster University, Hamilton, Ontario, Canada

Abstract

Learning Objectives After completing this course, the reader will be able to: Define the cancers most common in 15- to 29-year-olds.Identify the variations in cancer histology in this age group according to age, sex, and race/ethnicity.Interpret survival trend differences during the past quarter century.Interpret incidence and survival according to sex, race/ethnicity, and age groups.Discuss areas where progress has been suboptimal in managing cancer in 15- to 29-year-olds. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-6-590

Reference7 articles.

1. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995;Ries,1999

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCN20000: Dermoscopic Lesions in the Wild;Scientific Data;2024-06-17

2. Characteristics and variations in young adults with cutaneous melanoma: A national cancer database analysis;Journal of Surgical Oncology;2024-05-19

3. Myeloproliferative Neoplasms (MPNs);Pediatric Pathology of Hematopoietic and Histiocytic Disorders;2024-02-15

4. Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model;ACS Biomaterials Science & Engineering;2024-02-13

5. Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic review;Neuro-Oncology Advances;2023-12-10